Objective To explore the effect of nebulized inhalation of esketamine on postoperative sore throat (POST) in patients with general anesthesia trachea intubation. Methods A total of 66 patients undergoing selective surgical treatment via general anesthesia trachea intubation in supine position were selected as the research subjects. Patients were assigned to esketamine group (group S) or control group (group C) by employing the random number table method, with 33 cases in each group. Group S received nebulized inhalation of 25 mg esketamine plus 4 mL normal saline for 15 minutes, and group C received nebulized inhalation of 5 mL normal saline for 15 minutes. The mean arterial pressure (MAP) and heart rate immediately before nebulized inhalation, immediately anesthesia preinduction, 5 minutes after anesthesia induction, 30 minutes after anesthesia induction, 60 minutes after anesthesia induction, at the time of extubation, on the time of leaving Postanesthesia Care Unit (PACU), and POST occurrence after 2, 4, 8, 12, 24 hours of extubation, as well as the occurrence of adverse reactions were compared between patients of the two groups. Results There was no statistically difference in MAP and heart rate at various time points between the two groups (P>0.05). Compared with immediately before nebulized inhalation, group C exhibited decreased MAP 5 minutes after anesthesia induction, 30 minutes after anesthesia induction, 60 minutes after anesthesia induction, at the time of extubation, on the time of leaving PACU, whereas group S yielded decreased MAP and both groups interpreted decreased heart rate immediately before anesthesia induction, 5 minutes after anesthesia induction, 30 minutes after anesthesia induction, 60 minutes after anesthesia induction, at the time of extubation, and on the time of leaving PACU (P<0.05). Group S depicted lower POST incidence rate and severity after 4, 8, 12, and 24 hours of extubation as compared with group C (P<0.05). There was 1 patient suffering from nausea and vomiting in group S, and 2 patients suffering from nausea and vomiting in group C, and no statistically significant difference in the incidence rate of adverse reactions between the two groups (P>0.05). Conclusion Nebulized inhalation of esketamine before anesthesia can decreased the incidence rate of POST in patients with general anesthesia trachea intubation, and relieve POST severity, with a low incidence rate of adverse reactions.